Financial Architects (New Jersey)’s VanEck Pharmaceutical ETF PPH Stock Holding History

Financial Architects (New Jersey)’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-74	Closed	-$5K	–	630
2020 Q2	$5K	Buy	74 +1	+1%	+$60	﹤0.01%	729
2020 Q1	$4K	Hold	73	–	–	﹤0.01%	734
2019 Q4	$5K	Hold	73	–	–	﹤0.01%	767
2019 Q3	$4K	Buy	73 +1	+1%	+$57	﹤0.01%	855
2019 Q2	$4K	Hold	72	–	–	﹤0.01%	1036
2019 Q1	$4K	Hold	72	–	–	﹤0.01%	1258
2018 Q4	$4K	Buy	72 +1	+1%	+$61	﹤0.01%	1169
2018 Q3	$5K	Hold	71	–	–	﹤0.01%	1227
2018 Q2	$4K	Hold	71	–	–	﹤0.01%	1147
2018 Q1	$4K	Buy	71 +1	+1%	+$60	﹤0.01%	1263
2017 Q4	$4K	Hold	70	–	–	﹤0.01%	1341
2017 Q3	$4K	Hold	70	–	–	﹤0.01%	1322
2017 Q2	$4K	Buy	70 +1	+1%	+$57	﹤0.01%	1347
2017 Q1	$4K	Buy	+69	New	+$3.74K	﹤0.01%	1337

Other funds holding PPH

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Financial Architects (New Jersey)'s PPH Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2020, closing a stake of 74 shares — an estimated $5K sold.

Financial Architects (New Jersey) first reported a position in PPH in Q1 2017 and held it in 14 quarters. The position peaked at $5K in Q2 2020. 47 funds tracked by Wall St. Rank hold PPH as of Q3 2020.

Financial Architects (New Jersey) reported no remaining VanEck Pharmaceutical ETF position as of Q3 2020 after selling out during the quarter.
Financial Architects (New Jersey) sold 74 VanEck Pharmaceutical ETF shares in Q3 2020, an estimated $5K.
Financial Architects (New Jersey) first reported a position in VanEck Pharmaceutical ETF in Q1 2017 and held it in 14 quarters.
Financial Architects (New Jersey)'s VanEck Pharmaceutical ETF position peaked at $5K in Q2 2020.
47 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.